AGP Executive Report
Last update: 7 hours agoDutch Biotech: Amsterdam-based VectorY Therapeutics raised €74.5 million to advance a clinical trial of its gene therapy for ALS, targeting the TDP-43 protein. Invest-NL joined the round alongside international investors. Drug Oversight: Dutch antitrust regulators are probing Biogen over a test for its multiple sclerosis drug. Cleaner Shipping: The Netherlands has set aside €231 million to clean up inland vessels, but electric freight corridors are still needed to support the shift. Research Policy: The Senate narrowly approved a law allowing embryos to be created for research, while parliament called for a national AI strategy for higher education. Defence Technology: Belgium selected Thales’ GM200 MM/C radar, developed and produced in the Netherlands, for its new air-defence system.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.